Biological and Pharmacogenomics Bases of Gastrointestinal and Some Long-term Selective Serotonin Reuptake Inhibitors-induced Adverse Effects

Conclusion: This review highlights a number of polymorphisms associated with some of the key AEs encountered in SSRI treatments. Standardized study designs in pharmacogenomic evaluations hold great promise for replication of association findings.
Source: Current Pharmacogenomics and Personalized Medicine - Category: Genetics & Stem Cells Source Type: research